|
Leukaemia CARE |
Blackpole Road Worcester |
UNITED KINGDOM |
13/07/2022 |
Johnson & Johnson paid Leukaemia Care a fee of £240 for a representative to speak at a J&J Haematology Med Ed Nurse Study Day |
|
0 GBP |
240 GBP |
|
|
|
|
06/11/2024 |
Johnson & Johnson provided Leukaemia Care with a grant of £5000 to support the delivery of their core services including a helpline, support groups and hospital hubs |
- |
5 000 GBP |
0 GBP |
|
|
|
|
17/05/2024 |
Johnson & Johnson provided non-financial TOV to Leukaemia Care in the form of stand space at a J&J Haematology event for Healthcare professionals. The financial value of this support was £250. |
Johnson & Johnson provided non-financial TOV to Leukaemia Care in the form of stand space at a J&J Haematology event for Healthcare professionals. The financial value of this support was £250. |
0 GBP |
0 GBP |
|
Lymphoma Action |
Smeaton Close Aylesbury |
UNITED KINGDOM |
22/11/2024 |
Johnson & Johnson provided Lymphoma Action with a grant of £5000 to support content and webpage development for their Healthcare Professional Education project |
- |
5 000 GBP |
0 GBP |
|
|
|
|
09/10/2024 |
Johnson & Johnson provided Lymphoma Action with a fee of 348.33 GBP for participation in the MCL advisory board |
- |
0 GBP |
348 GBP |
|
Multiple Sclerosis Trust |
Bridge Road Letchworth Garden City |
UNITED KINGDOM |
17/03/2024 |
Johnson & Johnson provided a sponsorship fee of £40,000 to the MS Trust towards the cost of their healthcare professional conference |
- |
40 000 GBP |
0 GBP |
|
Myeloma UK |
22 Logie Mill Edinburgh |
UNITED KINGDOM |
13/07/2022 |
J&J paid Myeloma UK a fee of £200 for a representative to speak at a J&J Haematology Med Ed Nurse Study Day |
|
0 GBP |
200 GBP |
|
|
|
|
12/12/2023 |
Johnson & Johnson provided Myeloma UK a fee of £440 for two representatives to attend a workshop looking at the Economic Burden of Multiple Myeloma. |
- |
0 GBP |
440 GBP |
|
|
|
|
22/03/2024 |
Johnson & Johnson provided non-financial TOV to Myeloma UK in the form of stand space at a Johnson & Johnson Haematology event for Healthcare professionals. The financial value of this support was £250. |
Johnson & Johnson provided non-financial TOV to Myeloma UK in the form of stand space at a Johnson & Johnson Haematology event for Healthcare professionals. The financial value of this support was £250. |
0 GBP |
0 GBP |
|
|
|
|
26/09/2024 |
Johnson & Johnson provided sponsorship of £13,990 to Myeloma UK by paying the entry fee for ten of its' employees to participate in the annual fundraising Ride Myeloma 2024 event |
- |
13 990 GBP |
0 GBP |
|
|
|
|
17/05/2024 |
Johnson & Johnson provided non-financial TOV to Myeloma UK in the form of stand space at a Johnson & Johnson Haematology event for Healthcare professionals. The financial value of this support was £250. |
Johnson & Johnson provided non-financial TOV to Myeloma UK in the form of stand space at a Johnson & Johnson Haematology event for Healthcare professionals. The financial value of this support was £250. |
0 GBP |
0 GBP |
|
|
|
|
06/11/2024 |
Johnson & Johnson provided Myeloma UK with a grant of £19,400 to support the delivery of their core services including costs towards their Myeloma Info line, Ask the Nurse service, patient materials and information days |
- |
19 400 GBP |
0 GBP |
|
|
|
|
26/11/2024 |
Johnson & Johnson covered travel costs of £166.42 for Myeloma UK's involvement in an Access and Reimbursement Policy Roundtable meeting. |
Johnson & Johnson covered travel costs of £166.42 for Myeloma UK's involvement in an Access and Reimbursement Policy Roundtable meeting. |
0 GBP |
0 GBP |
|
Nat Rheumatoid Arthritis Society |
Nat Rheumatoid Arthritis Society Maidenhead |
UNITED KINGDOM |
01/01/2025 |
Johnson & Johnson provided the National Rheumatoid Arthritis Society (NRAS) with a grant of £10,000 towards their core activities to support people living with Rheumatoid Arthritis |
- |
10 000 GBP |
0 GBP |
|
PHA UK |
Newton Chambers Road Sheffield |
UNITED KINGDOM |
18/03/2024 |
Johnson & Johnson provided PHA UK with a grant of £7,000 towards the cost of their Pulmonary Hypertension best practice shared care meeting |
- |
7 000 GBP |
0 GBP |
